DUBLIN--(BUSINESS WIRE)--Aug 27, 2018--The "Global Peptide Therapeutics Market Analysis 2017 - Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This research report analyzes the global markets with in-depth insights. The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level.

Annual estimations and forecasts are provided from the year 2014 to 2025 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.

Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

Key Topics Covered

1 Introduction

2 Executive Summary

3 Market Analysis

4 Porters Five Force Analysis

5 Peptide Therapeutics Market by Type of Molecule

6 Peptide Therapeutics Market by Route of Administration

7 Peptide Therapeutics Market by Application

8 Peptide Therapeutics Market by Technology

9 Peptide Therapeutics Market by Type of Manufacturers

10 Peptide Therapeutics Market by Type

11 Geographical Segmentation

12 Vendor Landscaping

13 Company Profiles

Bachem Holding AG Sanofi Hoffmann-La Roche Ltd. Novartis AG GlaxoSmithKline Pfizer, Inc. Teva Pharmaceutical Industries Ltd. Bachem Holding AG Takeda Pharmaceutical Company Limited Amgen, Inc. Eli Lilly and Company Lonza Inc. Bristol-Myers Squibb (BMS) AstraZeneca PLC Novo Nordisk A/S

For more information about this report visit https://www.researchandmarkets.com/research/9dlllb/global_peptide?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180827005214/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Biopharmaceuticals



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/27/2018 04:58 AM/DISC: 08/27/2018 04:58 AM